Global Blood Culture Tests Market 2016-2020
About Blood Culture
Blood culture tests help detect microorganisms such as bacteria, yeast, and fungi in the blood. These tests also help identify blood stream infections (BSIs) such as septicemia, a serious and life-threatening complication. These tests guide physicians to offer proper treatment for infections.
Technavio’s analysts forecast the global blood culture tests market to grow at a CAGR of 7.25% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global blood culture tests market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of tests for bacteremia, fungemia, and mycobacteria.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Blood Culture Tests Market 2016-2020
Technavio recognizes the following companies as the key players in the global blood culture tests market: BioMérieux, BD, Roche Diagnostics, ThermoFisher Scientific, and Cepheid.
Other Prominent Vendors in the market are: AB Sciex, AdvanDX, Alere, Beckman Coulter, Bruker, Dade Behring¸ Eurogentec, IRIDICA, Nanosphere, and Siemens.
Commenting on the report, an analyst from Technavio’s team said: “Demand for rapid diagnostic tests will be a key trend for market growth. Rapid identification of microorganisms in clinical laboratories is of great value for the selection of optimal patient management strategies for inhibiting bacteria, viruses, fungi, mycobacteria, and parasites. There is a critical need for new technologies in the area of clinical microbiology, particularly for detecting BSIs that are responsible for the highest number of deaths worldwide. Rapid diagnostics tests offer rapid identification of pathogens, are cost-effective to a certain extent, and help in the effective targeting of antimicrobial therapy in hospitals.”
According to the report, use of automated blood culture systems will be a key driver for market growth. Blood culture tests that involve most of the microbiological studies are the second-most common procedure performed in medical settings to detect BSIs. Advanced automated systems such as BS's BacT/ALERT system, AccuMed International's ESP Culture system II, and Cepheid's GeneXpert system used for these tests help reduce the hands-on time, minimize infection detection time, and are easy to use. Conventional systems often used to provide false-positive results, which led to the development of advanced devices that have helped reduce false-positive results by 10%. These advanced systems have also reduced the duration of infection detection from 4-5 days to a 24-hour period for positive results.
Further, the report states that high cost of automated blood testing systems will be a challenge for the market. Automated blood culture test instruments are expensive, with real-time PCR instruments being costlier compared to other medical devices. BioRad's real-time PCR costs about $9,900, while that of Applied Biosystems is about $14,500. The cost of the systems has a negative impact on the market growth in developing countries compared to developed nations, as people cannot afford costly devices and tests. Though these instruments are one-time investment, their high cost prevents hospital authorities to purchase them. These hospitals use manual methods for blood culture testing.
BioMérieux, BD, Roche Diagnostics, ThermoFisher Scientific, Cepheid, AB Sciex, AdvanDX, Alere, Beckman Coulter, Bruker, Dade Behring¸ Eurogentec, IRIDICA, Nanosphere, and Siemens.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook